TOKYO, Japan - [Eisai Co., Ltd.] (ESAIY) and [PayPay Corporation] (PAYP) reported their Q1 2027 earnings calls, both of which outpacing market expectations. [Eisai Co., Ltd.] revealed a 15% revenue growth year-over-year, surpassing analyst expectations for a 12% rise. [Eisai's] CEO, Haruo Naito, attributed the success to the company's expanded oncology pipeline and strong sales of its flagship Alzheimer's disease treatment.
PayPay Corporation also reported strong Q1 2027 earnings, exceeding analyst estimates for net income. The company's Q1 net income reached ¥15.8 billion, significantly above analyst estimates of ¥12.5 billion. PayPay's CEO, Noriaki Nakatani, highlighted the company's growing e-commerce segment as a key driver of its earnings growth.
As a result, [Eisai Co., Ltd.]'s stock price surged 5% following the release of its Q1 2027 earnings report, while [PayPay Corporation]'s shares rose 3% on the news of its exceeded earnings expectations. Analysts predict that [Eisai Co., Ltd.] may see a potential 20% upside due to its strong performance, and that [PayPay Corporation] may experience a 15% increase in its stock price due to its continued growth in the e-commerce sector.